Status:
RECRUITING
Tracking Atrial Fibrillation After Intensive Care Admission
Lead Sponsor:
University of Oxford
Conditions:
Atrial Fibrillation New Onset
New Onset Atrial Fibrillation
Eligibility:
All Genders
16+ years
Brief Summary
Atrial fibrillation (AF) is a heart problem that causes an irregular heartbeat. It can cause the heart to beat more rapidly and reduce the heart's ability to pump blood around the body efficiently, ca...
Detailed Description
The study aims to determine whether it is feasible to screen patients to detect atrial fibrillation after treatment on an intensive care unit. Patients who develop new onset AF in ICU who have no hist...
Eligibility Criteria
Inclusion
- Willing and able to give informed consent for participation in the study, or favourable consultee advice for adults lacking capacity
- Male or Female,
- aged 16 years or above.
- Admitted to intensive care for \>24 hours
- New onset atrial fibrillation as confirmed by 12 lead ECG-
Exclusion
- History of atrial fibrillation
- Unable to undergo cardiac monitoring
- Previously included in the study
- Not anticipated by treating consultant to survive to ICU discharge (withdrawal or limitation of medical treatment at time of screening)
- Contraindication to anticoagulation
- Unable to wear the device for the prescribed monitoring period
- Implanted neurostimulator, as this may disrupt the ECG recording
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05229211
Start Date
February 1 2022
End Date
December 30 2025
Last Update
June 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals Trust
Oxford, Oxfordshire, United Kingdom, OX3 9DU